▲ Peaking
Business
FDA Panel Votes In Favor of Replimune’s Melanoma Treatment
An FDA expert committee has voted in favor of Replimune’s melanoma treatment, marking a significant shift for the company’s previously rejected drug.
Repl
1 trends tracked about this subject — the full history, oldest to newest below.